Draft:Robert Goldman (inventor)
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
Submission declined on 15 March 2026 by Robert McClenon (talk). This draft appears to be a duplicate of an existing article. Wikipedia does not permit multiple articles on the same topic.
Declined by Robert McClenon 6 months ago.
| |
Submission declined on 11 November 2025 by Pythoncoder (talk). This draft appears to contain text generated by a large language model (such as ChatGPT). You cannot use LLMs to generate, draft, or rewrite article content.
Declined by Pythoncoder 10 months ago.Please delete the portions which were LLM-generated, and summarize in your own words a range of independent, reliable, published sources that discuss the subject. If you have used an LLM but you believe that your use is covered by one of the two exceptions (basic copyediting and translation between two languages in which you are fully fluent), please provide a transcript of the prompt(s) you used while writing your draft (see the how-to guide). Reviewers can make mistakes. If you have not received any LLM assistance, you may seek a second opinion at the AfC Help Desk. See the advice page on large language models for more information. | |
Comment: This draft has information that is not in the article and should be added to the article. The article has information that is not in this draft. Please compare and combine the draft and the article.You may ask for advice about comparing and combining a draft and an article at the Teahouse. Robert McClenon (talk) 04:08, 15 March 2026 (UTC)
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Robert J. Goldman (born 1959) is an American inventor whose work has included early digital music commerce systems and the development of a regional drug-delivery catheter used in cancer treatment.[1][2]
Goldman developed systems in the late 1990s that linked digital music playback and distribution with online purchasing, and later founded a medical device company focused on regional chemotherapy delivery.[3]
Early career
[edit]Goldman began his career in the early 1980s in software and systems engineering. He worked as a programmer at Intel Corporation and later at Lockheed Missiles and Space, where he was involved in systems and software development.[4]
In the late 1980s and early 1990s, he held marketing and management positions in consumer and medical technology companies, including roles at Voit Sports and NCR Corporation’s Advanced Medical Systems division.[5]
GetMedia
[edit]In 1999, Goldman founded GetMedia, Inc., a company that developed technology linking radio and streaming playlists to e-commerce purchasing.[6]
The system enabled listeners to purchase music online from real-time radio broadcasts and streaming playlists. Wired described GetMedia as part of broader efforts to connect online media consumption with purchasing functionality during the emergence of web-based music distribution.[7]
Goldman is listed as the inventor on U.S. Patent No. 5,629,867, titled Selection and Retrieval of Music from a Digital Database, which describes a system for identifying and retrieving music from a digital catalog in connection with playback and user selection.[8]
Vascular Designs and IsoFlow
[edit]In 2002, Goldman founded Vascular Designs, Inc., a medical device company focused on regional drug-delivery technologies.[9]
He is listed as the inventor on patents covering the IsoFlow infusion catheter, a dual-balloon, multilumen catheter designed to isolate a targeted treatment region from blood flow while delivering therapeutic agents directly to localized vasculature.[10]
According to reporting by MedCity News, Goldman began developing the IsoFlow device following his sister’s diagnosis with colon cancer in the late 1990s.[11]
The IsoFlow catheter received U.S. Food and Drug Administration 510(k) clearance in 2009 and later obtained CE Mark approval in 2011.[12][13]
Clinical evaluation of dual-balloon infusion microcatheters has been described in peer-reviewed studies, including work led by interventional radiologist Wayne L. Monsky examining their use in regional chemotherapy delivery for hepatocellular carcinoma.[14]
Konnect Solutions
[edit]In the 2010s, Goldman founded Konnect Solutions, Inc., a company focused on mobile and wireless technologies related to customer engagement and contactless interaction.[15]
PrimeTime Media
[edit]PrimeTime Media was established in the 2025 as a digital media optimization company focused on online video content.[16]
The company provides services intended to optimize metadata, thumbnails, titles, and search visibility across existing video libraries. According to company materials, it operates on a performance-based business model in which it shares in incremental revenue generated from optimization efforts rather than charging upfront fees.[17]
References
[edit]- ↑ Jones, Christopher (May 11, 1999). "Log on, Tune in, Buy Now". Wired. Retrieved October 18, 2025.
- ↑ Blain, Loz (September 14, 2009). "Targeted chemotherapy – fighting cancer without the side effects". New Atlas. Retrieved October 18, 2025.
- ↑ Jones, Christopher (May 11, 1999). "Log on, Tune in, Buy Now". Wired. Retrieved October 18, 2025.
- ↑ Zaleski, Andrew (October 20, 2016). "Crowdfunding campaign seeks to make vision for infusion catheter a reality". MedCity News. Retrieved October 18, 2025.
- ↑ Zaleski, Andrew (October 20, 2016). "Crowdfunding campaign seeks to make vision for infusion catheter a reality". MedCity News. Retrieved October 18, 2025.
- ↑ Jones, Christopher (May 11, 1999). "Log on, Tune in, Buy Now". Wired. Retrieved October 18, 2025.
- ↑ Jones, Christopher (May 11, 1999). "Log on, Tune in, Buy Now". Wired. Retrieved October 18, 2025.
- ↑ US 5629867, Goldman, Robert J., "Selection and Retrieval of Music from a Digital Database", published 1997-05-06, assigned to GetMedia, Inc.
- ↑ "Vascular Designs, Inc". Archived from the original on March 2, 2012. Retrieved February 1, 2026.
- ↑ US 8251948, Goldman, Robert J., "Multi-function catheter and use thereof", published 2012-08-28, assigned to Vascular Designs, Inc.
- ↑ Zaleski, Andrew (October 20, 2016). "Crowdfunding campaign seeks to make vision for infusion catheter a reality". MedCity News. Retrieved October 18, 2025.
- ↑ "K081147 – ISOFLOW INFUSION CATHETER" (PDF). U.S. Food and Drug Administration. Retrieved October 18, 2025.
- ↑ "Vascular Designs, Inc. Receives CE Mark Approval for Its IsoFlow Infusion Catheter" (Press release). November 14, 2011. Retrieved October 18, 2025.
- ↑ Monsky, Wayne L. (2017). "Dual-balloon infusion microcatheter for drug-eluting bead transarterial chemoembolization in hepatocellular carcinoma". Diagnostic and Interventional Radiology. 23 (5): 350–356. doi:10.5152/dir.2017.17012. PMC 5669546. PMID 29097347.
- ↑ US 12133142, Goldman, Robert J., "Location detection systems and methods of use", published 2024-01-02, assigned to Konnect Solutions, Inc.
- ↑ "PrimeTime Media". Retrieved October 18, 2025.
- ↑ "PrimeTime Media". Retrieved October 18, 2025.
Please delete the portions which were LLM-generated, and summarize in your own words a range of independent, reliable, published sources that discuss the subject. If you have used an LLM but you believe that your use is covered by one of the two exceptions (basic copyediting and translation between two languages in which you are fully fluent), please provide a transcript of the prompt(s) you used while writing your draft (see the how-to guide). Reviewers can make mistakes. If you have not received any LLM assistance, you may seek a second opinion at the AfC Help Desk.
See the advice page on large language models for more information.